4
Changes in Ownership
BridgeBio Pharma, Inc. Filed Acc 0001209191-23-046512
Secretary, Treasurer & CFO sold 22,683 shares at $28.59 ($648,455)
- Secretary, Treasurer & CFO gave up 22,311 shares (to pay taxes)
- Secretary, Treasurer & CFO acquired 44,994 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
STEPHENSON BRIAN C · Secretary, Treasurer & CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +44,994 | 81,704 | D | ||
| 2023-08-16 | Shares withheld for taxes : show line 2 in the form 10b5-1 | −22,311 | $29.80 | $664,868 | 59,393 | D |
| 2023-08-17 | Sale : show line 3 in the form 10b5-1 | −22,683 | $28.59 | $648,455 | 36,710 | D |
| Open-market sales · 22,683 sh · avg $28.59 · $648,455 | ||||||
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-16 | Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Units | −1,709 | 5,130 | D |
| 2023-08-16 | Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Units | −778 | 4,669 | D |
| 2023-08-16 | Exercise or conversion : show line 6 in the form 10b5-1 Restricted Stock Units | −24,193 | 48,386 | D |
| 2023-08-16 | Exercise or conversion : show line 7 in the form 10b5-1 Restricted Stock Units | −946 | 8,519 | D |
| 2023-08-16 | Exercise or conversion : show line 8 in the form 10b5-1 Restricted Stock Units | −17,368 | 243,157 | D |
Loading xslF345X05/doc4.xml…